CYAD
Celyad Oncology SA American Depositary Shares
CYAD
CYAD
Delisted
CYAD was delisted on the 18th of May, 2023.
9 hedge funds and large institutions have $15.9M invested in Celyad Oncology SA American Depositary Shares in 2018 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
9
Holders Change
-1
Holders Change %
-10%
% of All Funds
0.21%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
4
Reduced
2
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Jane Street
New York
|
+$368K |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$53.1K |
| 3 |
Renaissance Technologies
New York
|
+$45.6K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$14.5K |
Top Sellers
| 1 |
Victory Capital Management
San Antonio,
Texas
|
-$627K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$3.63K |
| 3 |
II
Inspire Investing
Meridian,
Idaho
|
-$1K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Victory Capital Management
San Antonio,
Texas
| $14.6M | -$627K | -18,280 | -4% |
|
|
2
Jane Street
New York
| $586K | +$368K | +10,562 | +169% |
|
|
3
Renaissance Technologies
New York
| $230K | +$45.6K | +1,300 | +25% |
|
4
Morgan Stanley
New York
| $211K | – | – | – |
|
|
5
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $173K | +$53.1K | +1,551 | +44% |
|
|
6
UBS Group
Zurich,
Switzerland
| $50K | +$14.5K | +427 | +41% |
|
7
Zurich Cantonal Bank
Zurich,
Switzerland
| $3K | – | – | – |
|
8
Bank of Montreal
Toronto,
Ontario, Canada
| $3K | – | – | – |
|
|
TRCT
9
Tower Research Capital (TRC)
New York
| $1K | -$3.63K | -116 | -78% |
|
|
II
10
Inspire Investing
Meridian,
Idaho
| – | -$1K | -21 | Closed |
|